A Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection
A Multicentric, Prospective Clinical Investigation to Evaluate Microwave Imaging Via MammoWave® in a Population-based Screening Program for Early Breast Cancer Detection to Make Breast Cancer Screening More Accurate, Inclusive, and Female-friendly
Sponsor: ELAROS 24/7 Limited (UK)
Listed as NCT06291896, this NA trial focuses on Women's Health: Neoplasm of Breast and remains actively recruiting participants. Sponsored by ELAROS 24/7 Limited (UK), it has been updated 6 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Feb 2025 — Sep 2025 [monthly]
Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Apr 2024 — Jun 2024 [monthly]
Recruiting NA
First recorded
Mar 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ELAROS 24/7 Limited (UK)
- EVITA - Cancro Hereditário (Portugal)
- Fondazione Toscana Life Sciences (Italy)
- IMT School for Advanced Studies Lucca
- London South Bank University
- Servicio De Salud De Castilla La Mancha (Spain)
- Umbria Bioengineering Technologies
For direct contact, visit the study record on ClinicalTrials.gov .